학술논문
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study
Document Type
Letter
Author
Kastritis, E.; Terpos, E.; Roussou, M.; Fotiou, D.; Theodorakakou, F.; Ntanasis-Stathopoulos, I.; Kanellias, N.; Migkou, M.; Gavriatopoulou, M.; Dimopoulos, M.A.; Symeonidis, A.; Labropoulou, V.; Delimpasi, S.; Mancuso, K.; Zamagni, E.; Katodritou, E.; Rivolti, E.; Kyrtsonis, M.-C.; Hatjiharissi, E.; Cheliotis, G.; Manousou, K.
Source
In: American Journal of Hematology . (American Journal of Hematology, September 2023, 98(9):E226-E229)
Subject
Language
English
ISSN
10968652
03618609
03618609